9.850CAD+1.55%Mkt Cap: 704.28M $P/E: 164.171d ago
Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America. The company offers Minjuvi for relapsed or refr…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Pricier
P/B
Cheaper
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap704.28M $
Enterprise Value640.09M $
Revenue (TTM)371.74M $
Gross Profit145.82M $
Net Income (TTM)-3.91M $
Revenue/Share3.745 USD
Last Price9.850 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees830
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)164.17
P/E (Forward)37.88
PEG—
EV/EBITDA12.53
EV/Revenue1.72
P/S1.89
P/B1.23
EPS (TTM)0.06
EPS (Forward)0.26
52W Range
5.66097% of range9.980
52W High9.980 CAD
52W Low5.660 CAD
Profitability
Gross Margin44.49%
Oper. Margin7.13%
EBITDA Margin13.74%
Profit Margin-1.19%
ROE-0.70%
ROA-0.51%
Growth
Revenue Growth68.50%
Earnings Growth550.00%
Cash Flow & Leverage
Operating CF50.22M $
CapEx (TTM)24.54M $
FCF Margin13.01%
FCF Yield6.87%
Net Debt-53.46M $
Net Debt/EBITDA-1.05
Balance Sheet
Debt/Equity0.10
Current Ratio2.32
Quick Ratio1.56
Book Value/Sh8.013 CAD
Cash/Share1.458 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.829 CAD
Upside (mean)-0.2%
Target Range9.000 CAD – 12.00 CAD
CAD9.000-0.2% to meanCAD12.00
# Analysts7
Ownership
Shares Out.98.18M
Float60.23M
Insiders47.02%
Institutions18.01%
Short Interest
Short Ratio18.0d
Short % Out.1.65%
Shares Short1.73M
Short (prev mo.)1.80M
Technical
SMA 508.451 (+16.6%)
SMA 2006.766 (+45.6%)
Beta0.07
S&P 52W Chg20.05%
Avg Vol (30d)84.08K
Avg Vol (10d)61.42K
Technical Indicators
RSI (14)77.8
MACD0.3313
MACD Signal0.3218
MACD Hist.+0.0096
BB Upper9.996 CAD
BB Middle9.242 CAD
BB Lower8.488 CAD
BB Width16.32%
ATR (14)0.2670 CAD
Vol Ratio (20d)2.14x